Glassman Wealth Services’s Genmab GMAB Stock Holding History
Bought
Maintained
Sold
Other funds holding GMAB
HL
Glassman Wealth Services's GMAB Position: Q1 2024 in Review
Glassman Wealth Services sold out of Genmab (GMAB) in Q1 2024, closing a stake of 304 shares — an estimated $9.68K sold.
Glassman Wealth Services first reported a position in GMAB in Q4 2019 and held it in 17 quarters. The position peaked at $18.7K in Q4 2022. 227 funds tracked by Wall St. Rank hold GMAB as of Q1 2024.
- Glassman Wealth Services reported no remaining Genmab position as of Q1 2024 after selling out during the quarter.
- Glassman Wealth Services sold 304 Genmab shares in Q1 2024, an estimated $9.68K.
- Glassman Wealth Services first reported a position in Genmab in Q4 2019 and held it in 17 quarters.
- Glassman Wealth Services's Genmab position peaked at $18.7K in Q4 2022.
- 227 funds tracked by Wall St. Rank held Genmab as of Q1 2024.
Based on Glassman Wealth Services's 13F filing for Q1 2024, filed 3 May 2024.